Cybersecurity

Canadian supercomputers are transforming drug discovery: Can they deliver medicines faster?

27 sec read2 views0 listens

Researchers at Simon Fraser University have developed an AI framework called CGFlow, which accelerates the design of drug molecules by ensuring they can be synthesized in a laboratory. This advancement is crucial for reducing the time and cost associated with traditional drug discovery processes. As AI and supercomputing continue to integrate, pharmaceutical companies are likely to see faster development cycles and lower R&D costs.

Read the full article at Digital Journal

Want to create content about this topic? Use Nemati AI tools to generate articles, social posts, and more.

You Might Like

Biotech & PharmaAug 1729 sec read

Human Cell Atlas at 10: A Decade of Discovery and the Road to HCA 2.0

The Human Cell Atlas (HCA) celebrated its 10-year anniversary, marking significant advancements in single-cell and spatial data generation for tissue and organ systems. The project is now transitioning to HCA 2.0, focusing on scaling spatial atlases,...

Ali Nemati

Biotech & PharmaAug 1723 sec read

Pharma Races to Scale AI as Billions Flow into Drug Discovery

Billion-dollar investments are pouring into end-to-end AI platforms for drug discovery, enabling more powerful biological models through integrated datasets and reasoning workflows. This trend is driven by the potential to accelerate biomedical resea...

Ali Nemati

Health & MedicineAug 330 sec read

Episode 1153: Don't Use Vitamin C For This Either...

A recent randomized trial found that administering high-dose intravenous Vitamin C (10g) to comatose adults after out-of-hospital cardiac arrest did not improve organ function and, in fact, worsened outcomes. The study indicated worse organ function,...

Ali Nemati